› Forums › General Melanoma Community › Genomic study using Palbociclib
- This topic is empty.
- Post
-
- August 11, 2016 at 4:50 pm
I was diagnosed with Stage 4 metastatic melanoma of unknown orgin in March 2014. Over the course of two years I've been on interferon, then IL-2, Yervoy and Opvido. Had some good response with Opvido, but have stopped responding. I am currently enrolled in clinical study at Sammons Cancer Cener in Dallas. This is a genomic study and have been matched with the drug Palbociclib. This was recently apporved for breast cancer. Just wondering if anyone has any experience with this drug/study as it pertains to melanoma? Been on this for 3 wks (3wks on/ 1wk off) and so far side effects are tolerable. Thanks for any info!
- You must be logged in to reply to this topic.